Decathlon Capital Partners has made a growth investment in Amprion Inc., a San Diego-based company focused on diagnostic testing for neurodegenerative diseases. The investment aims to bolster Amprion's capacity to test for conditions including Parkinson's disease, Lewy body dementia, and Alzheimer's disease.

Financial terms of the deal were not disclosed. Amprion, founded in 2007, is led by CEO Russ Lebovitz. The capital infusion will support the expansion of its diagnostic testing services.

This investment signals continued interest from private equity in the specialized diagnostics sector, particularly in areas addressing significant unmet medical needs. For investors, it points to potential growth opportunities in companies developing advanced diagnostic tools for complex neurological conditions.